P023 Identification of regulated mechanistic pathways and genes to protect intestinal barrier injury by larazotide acetate in an IBD microenvironment
ECCO'20 Vienna
2020
P024 Evaluation of the clinical course of patients diagnosed with primary sclerosing cholangitis: single centre study
ECCO'20 Vienna
2020
P025 Evaluation of endoplasmic reticulum stress in intestinal mucosa from patients with Crohn’s disease
ECCO'20 Vienna
2020
P026 The impact of different dietary factors in the etiopathogenesis of inflammatory bowel disease: a retrospective case–control study
ECCO'20 Vienna
2020
P027 Repertoire analysis of memory T-cell receptors in Japanese patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P029 TRIM 21 protects against ulcerative colitis and colitic cancer via smad7 inhibition
ECCO'20 Vienna
2020
P030 Dynamics of intestinal inflammation and microbial dysbiosis in pregnant women with IBD and their infants
ECCO'20 Vienna
2020
P031 Therapeutic effect of OPS-2071 in a murine model of Crohn’s disease and in in vitro anti-inflammatory assays
ECCO'20 Vienna
2020
P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model
ECCO'20 Vienna
2020
P034 GB004, a novel gut-targeted prolyl hydroxylase inhibitor, induces HIF-1α target genes and is efficacious in mouse colitis
ECCO'20 Vienna
2020
P035 NUDT15 variance increases DNA-incorporated thiopurine metabolites and lymphocyte apoptosis in patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P036 A novel p53-mediated mouse model of inflammatory bowel disease-associated colorectal cancer
ECCO'20 Vienna
2020
P037 Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a−/− mouse model of colitis
ECCO'20 Vienna
2020
P038 A single-cell transcriptomics approach reveals high-resolution cellular signatures in Crohn’s disease
ECCO'20 Vienna
2020
P039 Regional distribution of TCR Vδ1 and TCR Vδ2 cells in healthy and inflamed mucosa of inflammatory bowel disease
ECCO'20 Vienna
2020
P040 Proteomic characterisation of serum extracellular vesicles in patients with inflammatory bowel diseases: a novel approach for biomarker discovery
ECCO'20 Vienna
2020